Formulary
Trastuzumab [Specialist drug]: Indications, Dosing, Side Effects and Interactions
Trastuzumab [Specialist drug] clinical drug profile including indications, dosing, side effects, cautions and interactions.
MedNext Academy | 3 min read
Trastuzumab [Specialist drug]: Indications, Dosing, Side Effects and Interactions
Trastuzumab [Specialist drug] clinical drug profile including indications, dosing, side effects, cautions and interactions.
Indications and dose
**Breast cancer**
- **Adult** (By Intravenous Infusion, Or By Subcutaneous Injection): Specialist drug - access specialist resources for dosing information.
**Gastric cancer**
- **Adult** (By Intravenous Infusion): Specialist drug - access specialist resources for dosing information.
Contraindications
For trastuzumab [Specialist drug] Severe dyspnoea at rest
Side effects
For trastuzumab [Specialist drug] Common or very common With parenteral use Alopecia; anaemia; angioedema; anxiety; appetite decreased; arrhythmias; arthralgia; arthritis; asthenia; asthma; breast abnormalities; cardiomyopathy; chest pain; chills; constipation; cough; cystitis; depression; diarrhoea; dizziness; drowsiness; dry eye; dry mouth; dyspnoea; excessive tearing; eye inflammation; fever; gastrointestinal discomfort; haemorrhage; haemorrhoids; headache; heart failure; hepatic disorders; hyperhidrosis; hypersensitivity; hypotension; increased risk of infection; influenza like illness; infusion related reaction (may be delayed); insomnia; leucopenia; malaise; mucositis; muscle complaints; muscle tone increased; nail disorders; nausea; neutropenia; neutropenic sepsis; oedema; oral disorders; pain; palpitations; paraesthesia; peripheral neuropathy; renal disorder; respiratory disorders; rhinorrhoea; skin reactions; taste altered; thrombocytopenia; tremor; vasodilation; vomiting; weight decreased Uncommon With parenteral use Deafness; interstitial lung disease; pericardial effusion Frequency not known With parenteral use Cardiac disorder; cardiogenic shock; glomerulonephritis; haematotoxicity; hyperkalaemia; hypertension; hypoprothrombinaemia; hypoxia; left ventricular dysfunction; post procedural infection; pulmonary fibrosis; pulmonary oedema; renal failure; tumour lysis syndrome Side-effects, further information Heart failure Consider discontinuing treatment in cases of left ventricular dysfunction. Interstitial lung disease and pneumonitis Interstitial lung disease and pneumonitis, including fatal events, have been reported; if confirmed treatment should be discontinued.
Medicinal forms
Solution,Solution
Clinical governance
**Author:** MedNext Clinical Team. **Clinical reviewer:** Dr Shameer Deen, MBBS, MS, MRCS. **Sources:** BNF, Indian Pharmacopoeia, CIMS India. **Correction:** Report errors at support@mednext.academy.
Inside MedNext for this topic
- 411 MedNext-authored chapters
- 80,000+ MCQ bank
- 15 study modes
- Growing visual cheat sheets
Study modes
- Notes
- MCQ
- Audio
- Video
- Visual
- 3D Anatomy
- Trace
- Flashcards
- Mnemonics
- Image Bank
- Clinical
- Microscopy
- Audio QBank
- Cadaver
- Book Match
Continue reading
Subject HubPharmacology Hub
All pharmacology resources in one place.
Drug SchedulesIndian Drug Schedules
Schedule H, H1, X and G classifications.
FormularyBrowse all drugs
Search 1,850+ drug profiles.
Study Trastuzumab [Specialist drug] in the MedNext app
Challenge yourself with targeted pharmacology MCQs on this drug class. Every explanation links back to the chapter that teaches the concept.
Start drug challengeExplore the full formulary

